Get started
Work

Neurocognition in Early-Onset Schizophrenia and Schizoaffective Disorders

Year: 2010
Type: article
DOI: 10.1016/j.jaac.2009.11.001
Authors: Stephen R. Hooper, Anthony J. Giuliano, Eric A. Youngstrom, David Breiger, Linmarie Sikich, Jean A. Frazier, Robert L. Findling, Jon McClellan, Robert M. Hamer, Benedetto Vitiello, Jeffrey A. Lieberman
Institutions: Cambridge Health Alliance, Harvard University, University of Washington, Case Western Reserve University, National Institutes of Health, New York State Psychiatric Institute, Columbia University
Language: English
Field: Medicine
Open Access status: bronze
Funders: U.S. Department of Health and Human Services, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, CeNeRx, University of Washington, Case Western Reserve University, Seattle Children's Research Institute, Supernus Pharmaceuticals, Otsuka America, H. Lundbeck A/S, National Institutes of Health, Genentech, Allergan, National Institute of Mental Health, National Center for Research Resources, School of Medicine, University of North Carolina at Chapel Hill
Awards: TREATMENT OF EARLY ONSET SCHIZOPRENIA SPECTRUM (TEOSS), G3188168708, TREATMENT OF EARLY ONSET SCHIZOPHRENIA SPECTRUM (TEOSS), General Clinical Research Center, TREATMENT OF EARLY ONSET SCHIZOPHRENIA SPECTRUM (TEOSS), TREATMENT OF EARLY ONSET SCHIZOPHRENIA SPECTRUM (TEOSS), G9000018574
OpenAlex ID: W4255117635
FWCI: 0.436
Cites: 50
Cited by: 14
Related to: 10